283 related articles for article (PubMed ID: 19026741)
1. Assessment of low level whole-body soman vapor exposure in rats.
Genovese RF; Benton BJ; Johnson CC; Jakubowski EM
Neurotoxicol Teratol; 2009; 31(2):110-8. PubMed ID: 19026741
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-level inhalation exposure to cyclosarin on learned behaviors in Sprague-Dawley rats.
Genovese RF; Benton BJ; Shippee SJ; Jakubowski EM; Bonnell JC
J Toxicol Environ Health A; 2006 Dec; 69(24):2167-80. PubMed ID: 17062507
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evaluation of rats following low-level inhalation exposure to sarin.
Genovese RF; Mioduszewski RJ; Benton BJ; Pare MA; Cooksey JA
Pharmacol Biochem Behav; 2009 Feb; 91(4):517-25. PubMed ID: 18835292
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats.
Genovese RF; Benton BJ; Lee EH; Shippee SJ; Jakubowski EM
Toxicology; 2007 Mar; 232(1-2):109-18. PubMed ID: 17234319
[TBL] [Abstract][Full Text] [Related]
5. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy.
Perkins MW; Wong B; Rodriguez A; Devorak JL; Alves DA; Murphy G; Sciuto AM
Chem Biol Interact; 2013 Dec; 206(3):452-61. PubMed ID: 23886498
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cognitive and biochemical effects of low-level exposure to sarin in rhesus and African green monkeys.
Genovese RF; Oubre JL; Jakubowski EM; Fleming PJ; Saxena A; Rockwood GA; Tipparaju P; Willmore CB
Toxicology; 2007 Feb; 231(1):11-20. PubMed ID: 17126468
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition.
Dabisch PA; Davis EA; Renner JA; Jakubowski EM; Mioduszewski RJ; Thomson SA
Inhal Toxicol; 2008 Jan; 20(2):149-56. PubMed ID: 18236229
[TBL] [Abstract][Full Text] [Related]
8. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs.
Perkins MW; Pierre Z; Rezk P; Sabnekar P; Kabra K; Chanda S; Oguntayo S; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2010 Jun; 245(2):171-8. PubMed ID: 20206646
[TBL] [Abstract][Full Text] [Related]
9. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
[TBL] [Abstract][Full Text] [Related]
10. Determination of miosis threshold from whole-body vapor exposure to sarin in African green monkeys.
Genovese RF; Benton BJ; Oubre JL; Fleming PJ; Jakubowski EM; Mioduszewski RJ
Toxicology; 2008 Feb; 244(2-3):123-32. PubMed ID: 18096290
[TBL] [Abstract][Full Text] [Related]
11. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
12. Biochemical effects of low level exposure to soman vapour.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop H
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: increased startle reactivity and perseverative behavior.
Langston JL; Wright LK; Connis N; Lumley LA
Pharmacol Biochem Behav; 2012 Jan; 100(3):382-91. PubMed ID: 21983492
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
16. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.
Dabisch PA; Horsmon MS; Muse WT; Mioduszewski RJ; Thomson S
Toxicol Sci; 2007 Nov; 100(1):281-9. PubMed ID: 17693423
[TBL] [Abstract][Full Text] [Related]
18. Exposure duration modifies the effects of low level lead of fixed-interval performance.
Cory-Slechta DA
Neurotoxicology; 1990; 11(3):427-41. PubMed ID: 2284049
[TBL] [Abstract][Full Text] [Related]
19. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits.
Grauer E; Chapman S; Rabinovitz I; Raveh L; Weissman BA; Kadar T; Allon N
Toxicol Appl Pharmacol; 2008 Mar; 227(2):265-74. PubMed ID: 18164360
[TBL] [Abstract][Full Text] [Related]
20. Effects of sarin on the operant behavior of guinea pigs.
Langston JL; Adkins AL; Moran AV; Rockwood GA; Deford MS
Neurotoxicol Teratol; 2005; 27(6):841-53. PubMed ID: 16046097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
